万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>妇产科学
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生2>>生殖生物学

HUMAN REPRODUCTION UPDATE《人类生殖医学前沿》 (官网投稿)

简介
  • 期刊简称HUM REPROD UPDATE
  • 参考译名《人类生殖医学前沿》
  • 核心类别 SCIE(2023版), 外文期刊,
  • IF影响因子
  • 自引率2.30%
  • 主要研究方向医学-OBSTETRICS & GYNECOLOGY 妇产科学;REPRODUCTIVE BIOLOGY 生殖生物学

主要研究方向:

等待设置主要研究方向
医学-OBSTETRICS & GYNECOLOGY 妇产科学;REPRODUCTIVE BIOLOGY 生殖生物学

HUMAN REPRODUCTION UPDATE《人类生殖医学前沿》(双月刊). Human Reproduction Update is the leading journal in its field with a Journal Impact FactorTM&...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊网址:https://academic.oup.com/humupd

3、投稿网址:http://mc.manuscriptcentral.com/hru

4、官网邮箱:editorial@humanreproduction.co.uk

5、官网电话:+44 (0)1954 212404(编辑部)

6、期刊刊期:双月刊,一年出版6期。

2021716日星期五

                                 

 

投稿须知【官网信息】

 

Information for authors

Human Reproduction Update operates a pre-submission proposal system. Authors wishing to submit a manuscript must first send a review proposal to the Editorial Office (editorial@humanreproduction.co.uk). For guidance on preparing a proposal, see Submission of proposals. Proposals will be evaluated by the Editorial Review Team and will only be approved for submission if they provide a substantial update to the field. Notification of approval for submission will be sent by the Editorial Office and a manuscript stub will be placed in corresponding authors’ Author Centre in the journal’s online submission portal. For instructions on formatting manuscripts of approved proposals, see our Guidelines for preparing manuscripts. Once you have prepared your manuscript according to the instructions below please visit the online submission website.

Please follow the instructions for submission carefully; the Editors reserve the right to return proposals and manuscripts that do not comply with instructions.

Please note that by submitting a manuscript for publication in Human Reproduction Update you confirm that you are the corresponding/submitting author and that Oxford University Press (OUP) may retain your email address for the purpose of communicating with you about the manuscript. You agree to notify OUP immediately if your details change. If your article is accepted for publication OUP will contact you using the email address you have used in the registration process.

1 - Scope

Human Reproduction Update aims to provide comprehensive, authoritative, up-to-date, balanced reviews covering all areas of human reproduction. Basic, translational and clinical topics will be considered including reproductive physiology and pathology, reproductive endocrinology, andrology, gonad function, gametogenesis, fertilization, embryo development, implantation, early pregnancy, reproductive genetics, genetic diagnosis, reproductive oncology, contraception, infertility treatment, psychology and counselling, ethics and social issues.

2 - Submission of proposals

Proposals for manuscripts should be emailed to the Editorial Office, at editorial@humanreproduction.co.uk, for consideration by the Editorial Review Team. The Editorial Review Team is composed of members of the Editorial Board, the Deputy Editor and the Editor-in-Chief.

ORCID iDs are required for corresponding authors of all proposals sent to Human Reproduction Update and are recommended for all other authors. The Journal will include all supplied iDs in published articles. ORCID provides a persistent digital identifier that is unique to individual authors. Learn more at orcid.org. ORCID iDs can be requested at ORCID.org and can be linked to User Accounts in the journal's online submission portal.

Notification of approval for submission will be sent out by the Editorial Office, together with any recommendations/updates for the proposed manuscript. This will place a manuscript submission stub in the corresponding author's Author Centre in the manuscript submission portal. Only those proposals that provide a substantial update to the field will be approved for submission. Approval for submission does not guarantee acceptance for publication.

Manuscripts can only be able to be submitted through these processes. All decisions of the Editorial Review Team are final.

Proposals for narrative reviews

The narrative review proposal template must be completed. Proposals should clearly state the proposed title, authors, key words, corresponding author & their contact details, proposed manuscript submission date, review type, table of contents, and abstract (300-400 words).

Proposal abstracts for narrative reviews should explicitly substantiate why an update is needed and how the proposed review impacts clinical practice and/or what significance it has for reproductive clinicians and scientists.

Examples of well-formatted proposals can be found here. Incomplete proposals will be returned.

Systematic reviews (with or without meta-analysis)

The systematic review proposal template must be completed. Proposals should clearly state the proposed title, authors, key words, corresponding author & their contact details, proposed manuscript submission date, review type, table of contents, and abstract (300-400 words).

Proposal abstracts for systematic reviews must clearly define the research question and/or primary outcome(s); they should clearly substantiate the need for the proposed review and how it will update the field beyond recent publications. When possible, the proposal abstract should include details of data analyses, including literature search terms, databases interrogated & time period covered, exclusion/inclusion criteria, model of analysis/analyses, quality and bias assessment, and outcome measure(s). Finally, if possible, proposals should be accompanied by a reference list of articles included in the analysis/analyses.

Examples of well-formatted proposals can be found here. Incomplete proposals will be returned.

3 - Guidelines for preparing manuscripts

Manuscript length

Manuscripts should have a structured abstract of less than 500 words, 6000-10000 words of text, 2-5 tables, 3-5 figures and 200-300 references. Manuscripts should be written using clear and concise English, with standard English spelling and conventions.

Style

Manuscripts should be written using clear and concise English. Special care should be taken regarding the overall flow and readability of the paper.

For Biochemical and Bacterial terminology please follow the International Union of Pure and Applied Chemistry (IUPAC) and International Union of Biochemistry and Molecular Biology (IUBMB) recommendations. Genotypes must be italicized; phenotypes should not.

Units of measurement and abbreviations

Units of measurement should be in Systéme International (SI) units and those recommended by the IUPAC should be used wherever possible. Standard units of measurements and chemical symbols of elements may be used without definition in the body of the paper.

Abbreviations should be given in brackets after their first mention in the abstract, again at first mention in the main manuscript and finally in each figure legend and table footnote. Please note that abbreviation lists are not permitted.

Centrifugation rates should be given at g values rather than rpm, as these will vary according to centrifuge rotor diameter.

Format

Manuscripts should be submitted in Microsoft Word format. The text should be double spaced and continuous line numbers are mandatory.

Manuscript structure (listed in order of appearance on the manuscript)

Title page (page 1)

A. Title

Should not exceed 25 words and should be specific and informative.

In accordance with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, all systematic reviews should be identified as such in the manuscripts title.

B. Running title

Should not exceed 50 characters.

C. Authors

Give first name and family name of all authors.

D. Address

The department, institution, city and country should be given with postal code for each author. An e-mail address and ORCID iD are required for the corresponding author, who should be clearly identified.

Table of contents (page 2)

A concise Table of Contents should include the first and second level headings used throughout the manuscript. (Lower level headings are permitted in the main manuscript text, but the Table of Contents must be limited to first and second level headings.)

Abstract (page 3)

The abstract should be 400-500 words, clearly summarising the contents of the manuscript. It should be formatted with the headings:

Background

Objective and rationale

Search methods

Outcomes

Wider implications

Use our template for assistance. Note that online abstracts are published for viewing in isolation to the main body of the manuscript and should be self explanatory.

Key words

A minimum of five, and maximum of ten, key words should be listed at the end of the abstract. Key words, together with the title and abstract, are used for online searches; they should be specific and relevant to the manuscript.

Text body of the manuscript (from page 4)

Comprehensive narrative reviews should provide a general background of the focal topic, followed by the updated knowledge, then future perspectives which may be interesting to reproductive experts and to other scientists and finally a summarising conclusion. Comprehensive review manuscripts must include introduction and discussion sections using first level headings Introduction and Discussion. First level headings of Methods and Results are optional.

Systematic reviews, with or without a meta-analysis, MUST be reported in accordance with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and aim to ensure the transparent and complete reporting of systematic reviews and meta-analyses.

Authors must include the relevant PRISMA flow chart and checklist with their submission (e.g. PRISMA, PRISMA Individual Meta-Analysis, PRISMA Network Meta-Analyses).

Systematic reviews and meta-analyses that determine diagnostic accuracy should be reported according to QUADAS (Quality Assessment of Studies of Diagnostic Accuracy included in Systematic Reviews) and should be accompanied by the PRISMA Diagnostic Test Accuracy flow chart and checklist.

Systematic review and meta-analyses of observational studies should be reported according to MOOSE (Meta-analysis of Observational Studies in Epidemiology).

It is recommended that all systematic reviews are prospectively registered in a review proposal registry (e.g. PROSPERO).

Systematic review manuscripts should be organised with the following headings:

Introduction

Methods

Results

Discussion

Data availability

A data availability statement, referring to new data generated or third-party data analysed, is required. The statement should describe and provide means of access, where possible, by linking to the data or providing the required unique identifier. More information and examples of Data Availability statements can be found here.

Acknowledgements

Personal acknowledgements should precede those of institutions or agencies. Only non-financial support should be included in the Acknowledgements.

Authors’ roles

Human Reproduction Update adheres strictly to the International Committee of Medical Editors (ICMJE) guidelines regarding ‘Authorship and Contributorship’. Manuscripts must include details for the contributions of each author, including participation in study design, execution, analysis, manuscript drafting and critical discussion.’

Criteria for authorship is:

Substantial contributions to the conception or deign of the work; or the acquisition, analysis, or interpretation of data for the word; AND

Drafting the work or revising it critically for important intellectual content; AND

Final approval of the version of the published; AND

Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

All authors must meet all four of the above contributions.

Funding

In line with the World Association of Medical Editors (WAME) guidelines, the journal considers it the responsibility of the author to protect the integrity of the research record from bias related to the source of funding by fully declaring all sponsorships, the roles played by sponsors in the research, as well as institutional affiliations and relevant financial ties. Funding sources should be listed in the manuscript in the Funding section. Grant numbers should be given.

Where no specific funding was sought for the study, and departmental funds were used to support the authors throughout the study period and manuscript preparation, this should be acknowledged, giving department names.

Oxford Journals will deposit all NIH-funded articles in PubMed Central. Authors must ensure that manuscripts are clearly indicated as NIH-funded. More details are available in our Author Resource Centre. Oxford Journals will also deposit all articles published under an Open Access licence in PubMed Central.

In order to meet funding requirements authors are required to name their funding sources, or state if there are none, during the online submission process. For further information on this process or to find out more about CHORUS, visit the CHORUS initiative.

Conflict of interest

In line with ICMJE recommendation, Human Reproduction Update requires that all authors declare any interests that they (or others) could consider leading to a perceived bias. These biases (or perceived biases) can be of a financial, personal or professional nature, including (but not restricted to):

Financial interest in, or arrangement with, a company whose product was used in any included studies or is referred to in the manuscript. This includes directorships, direct company employment, shareholding (personal or immediate family), consultancy, membership of Advisory Boards, paid lectures, research grants or any other involvement that the author can perceive that a third party may consider creates a conflict of interest.

Financial interest in, or arrangement with, a competing company.

Direct payment to an author(s) from any source for the purpose of writing the manuscript.

Any other financial connections, direct or indirect, or other situations that might raise the question of bias in the work reported or the conclusions, implications, or opinions stated (including pertinent commercial or other sources of funding for the individual author(s) or for the associated department(s) or organisations(s), personal relationships, or direct academic competition).

Figure legends

A copy of any figure legends should be included in main manuscript document. Each legend must be self contained, without the need for cross-reference to the main text. All symbols and abbreviations used in the figure must be defined in the legend. Care should be taken to present data clearly and without unnecessary descriptive detail (e.g. forest plots).

References

Citations within the text:

Authors are responsible for the accuracy of the references. Each reference should be cited by author and date. If there are two authors please list both; if there are more than two authors please use first author then et al.

Permission to cite personal communications (J. Smith, personal communication) should be obtained by the corresponding author. Unpublished data should be cited as (unpublished data) and should not be included in the reference list. Either of the above should be used only when essential.

References to papers accepted for publication but not yet published should be cited as such; e.g. Bloggs A (2007, in press).

Reference list

References should be listed in alphabetical order. Please use the following style.

Authors. Title. Journal year: issue; pg-pg

Note that correct punctuation and journal abbreviations must be used in order to run the search programs used to edit the manuscript when being prepared for publication. Incorrectly typed references take a lot of time to correct, for which we reserve the right to charge.

Up to 10 authors should be included after which et al. should be used. Refer to the following examples.

Biggers JD, McGinnis LK. Evidence that glucose is not always an inhibitor of mouse preimplantation development in vitro. Hum Reprod 2001:16;153-163.

Gekas J, Thepot F, Turleau C, Siffroi JP, Dadaoune JP, Briault S, Rio M, Bourouillou G, Carre Pigeon F, Wasels R et al. Chromosomal factors of infertility in candidate couples for ICSI: an equal risk of constitutional aberrations in women and men. Hum Reprod 2001:16; 82-90.

Elliot WH, Elliot DC. Biochemistry and Molecular Biology. 2nd edn, 2001. Oxford University Press, Oxford, UK.

Warren MA, Li TC, Klentzeris D. Cell biology of the endometrium: histology, cell types and menstrual changes. In Chard T and Grudzinskas JG (eds) The Uterus. 1994. Press Syndicate of the University of Cambridge, Cambridge, UK, pp.94-125.

References that are accepted for publication but not yet published should be listed as:

Bloggs A. In vitro fertilization. Hum Reprod Update 2021: in press.

Papers published on Advance Access are citeable using the DOI and publication date. An example of an Advance Access citation is given below:

Gilad, Y. and Lancet, D. Population Differences in the Human Functional Olfactory Repertoire. Mol. Biol. Evol. Advance Access published March 5, 2003, doi:10.1093/molbev/msg013.

Tables

Each table should be numbered consecutively with Arabic numerals (i.e. Table I, Table II etc.). Human Reproduction Update remains a print journal. Please avoid complex constructions; tables should be formatted to print page dimensions and must be legible at 100%. Tables should be produced using Word or Excel format. Each table should be self explanatory and include a brief descriptive title. Footnotes to the table indicated by superscript lowercase letters are acceptable but should not include extensive detail.

In-text reference to the tables in the manuscript text should be sequential; i.e. Table I then II etc.

Figures

For review purposes, figure file format is flexible. However, high-quality, individual, editable figure files will be required before final acceptance. Ideally, figures should be in TIFF, EPS or JPEG format at a minimum of 600dpi at print size. Human Reproduction Update remains a print journal; care should be taken to ensure images and text are legible at print dimensions.

In preparing graphs please avoid background tints and 3D effects. Where possible, please maintain a consistent label size and aspect ratio (the x/y axis ratio) throughout the manuscript. Axes titles should be clear and legible at print size.

Re-use of previously published tables and figures

Republication of previously published tables and illustrations should be avoided in Human Reproduction Update. If previously published tables, illustrations or text are to be included, then this should be clearly indicated in the manuscript and the permission must be obtained from the copyright holder and/or publishing licence holder. Copies of such permission letters should be submitted with the manuscript.

Third party content in Open Access papers

If you will be publishing your paper under an Open Access licence but it contains material for which you do not have Open Access re-use permissions, please state this clearly by supplying the following credit line alongside the material:

Reproduced from Author, Original publication, year of original publication, with permission of [rights holder], under exclusive licence of [Publisher]. Please note that subsequent reuse of this [figure/table] is not permitted under the current article’s Open Access licence. Permission for reuse must be requested from [Publisher].

……

更多详情:

https://academic.oup.com/humupd/pages/General


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭